Concepedia

Lakshmanan Annamalai

LA

22

Publications

2.9K

Citations

18

H-Index

2006

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Harvard University

Massachusetts General Hospital

Athinoula A. Martinos Center for Biomedical Imaging

Boston College

Lakshmanan Annamalai is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, radiation oncology, and immunology.

Top concepts

Publications per year

2006–2020

22

Publications

22

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

Paul Nghiem, Shailender Bhatia, Evan J. Lipson et al. · New England Journal of Medicine · 2016 · 1.2K citations · Full text

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma

Alexander C. Huang, Robert Orlowski, Xiaowei Xu et al. · Nature Medicine · 2019 · 683 citations

, , +11

LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis

David Bauché, Barbara Joyce-Shaikh, Renu Jain et al. · Immunity · 2018 · 188 citations · Full text

, , +8

Cardiomyocyte <i>Ogt</i> is essential for postnatal viability

Lewis J. Watson, Bethany W. Long, Angelica M. DeMartino et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2013 · 87 citations · Full text

, , +19

The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers

Michael T. Barrett, Elizabeth Lenkiewicz, Smriti Malasi et al. · Breast Cancer Research · 2018 · 83 citations · Full text

Rows per page

1–5 of 22